ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 32 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $887,000 | +49.6% | 40,344 | -78.3% | 0.12% | -62.5% |
| Q3 2019 | $593,000 | -53.4% | 185,800 | -47.6% | 0.32% | -80.0% |
| Q2 2019 | $1,273,000 | -48.7% | 354,713 | -48.0% | 1.60% | +34.3% |
| Q1 2019 | $2,481,000 | -11.4% | 681,500 | -27.0% | 1.19% | +93.5% |
| Q4 2018 | $2,799,000 | -27.8% | 933,050 | +16.5% | 0.62% | +24.2% |
| Q3 2018 | $3,876,000 | +6582.8% | 801,242 | +7489.0% | 0.50% | +24700.0% |
| Q3 2015 | $58,000 | -95.2% | 10,558 | -95.0% | 0.00% | -95.5% |
| Q2 2015 | $1,204,000 | – | 212,017 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |